🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Josef Bednařík

Eli Lilly (United States)

ORCID: 0000-0001-7420-2383
MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

79 citations

Gil I. Wolfe, Srikanth Muppidi, Heinz Wiendl, Kenji P. Fujita, Fanny O’Brien +94 more

25 citations

Andrzej Szczudlik, Antanas Vaitkus, Csilla Rózsa, Anna Kostera‐Pruszczyk, Petr Hon +20 more

7 citations

Tomáš Horák, Olesja Parmová, Josef Bednařík, Stanislav Voháňka, Magda Horáková

29 citations

René Labounek, Tomáš Horák, Magda Horáková, Petr Bednařík, Miloš Keřkovský +10 more

26 citations

Jan Valošek, Tomáš Horák, Alena Svátková, Petr Bednařík, Ľubomír Vojtíšek +7 more

0 citations

Atul Malhotra, Ronald R. Grunstein, Ali Azarbarzin, Scott A. Sands, Virend K. Somers +7 more

0 citations

Josef Bednařík, Atul Malhotra